They’re necessary, but not necessarily nice.
And every med has its own side-effects.
Just as different people experience different difficulties.
But here‘s the low-down on some possible side-effects.
I hope you don’t have to suffer any of them. (Or as few as possible.)
Posted in
Epilepsy,
Medication IssuesTags:
antiepilepsy drug side effects,
Ativan,
Banzel,
Carbatrol,
depakote,
Diamox,
Diastat Acudial,
Dilantin,
Felbatol,
Frisium,
Gabitril,
Hp Acthar Gel,
Keppra,
Klonopin,
Lamictal,
Lyrica,
Mysoline,
Neurontin,
Ocopri,
Onfi,
Peganone,
Perampanel,
Phenobarbital,
Phenytek,
Rufinamide,
Sabril,
Tegretol,
Topamax,
Tranxene,
Trileptal,
Viibryd,
Vimpat,
Zarontin,
Zonegran
A strong relationship between migraines and epilepsy has long been suspected.
But now it is fact, according to extensive research cited by Steven Karceski, MD in Practical Neurology Magazine.
Posted in
EpilepsyTags:
co-existance,
Depacon,
depakote,
Epilepsy,
Keppra,
migraines,
Neurontin,
Research,
symptoms,
Topamax,
treatments,
triggers,
Zonegran
When Keppra was approved as an add-on medicine for partial seizures, including partial seizures with secondary generalization, at the time, it was suggested that Keppra might have a universally positive effect on all seizure types.
That’s all fine and good for researchers who aren’t struggling with epilepsy every day. But here’s a random sampling of what real people – like you and me – have to say…
Posted in
Epilepsy,
Medication Issues,
TipsTags:
behavioral consequences,
controversy,
drug-resistant,
Epilepsy,
Keppra,
real people's stories,
the bad,
the good,
the ugly
“Suicide Risk from 11 Anti-Epilepsy Drugs,” headlines blared across the country.
But we’re still here.
Was it sensationalism by the journalists, irresponsibility by the pharmaceutical industry or laxness of the FDA?
Posted in
Epilepsy,
Medication Issues,
ResearchTags:
anti-epilepsy drugs,
depakote,
depression,
FDA analysis,
Felbatol,
Gabitril,
Keppra,
Lamictal,
Lyrica,
Neurontin,
suicide risk,
Tegretol,
Topamax,
Trileptal,
Zonegran
According to the Epilepsy Foundation, mothers taking seizure medication, risk birth defects of 4 to 8 percent — compared with 2 to 3 percent for all babies. Not much of a difference.
But the risk seems to be highest when multiple seizure medications are taken. Yet, without medication, uncontrolled seizures may deprive the baby of oxygen. Seizures can also increase the risk of miscarriage or stillbirth.
So, it’s important, as you know, to get the right balance.
Posted in
Epilepsy,
Medication Issues,
ResearchTags:
Barbiturates,
category C antiepileptic drugs,
Depakote (Valproic Acid),
Dilantin (Phenytoin),
Epilepsy,
Keppra,
Lamictal,
Lyrica,
medication dangers,
multiple seizure medications,
Neurontin,
Phenobarbital,
pregnancy,
Tegretol (Carbamazepine and Carbatrol),
Topamax,
Trileptal,
uncontrolled seizures,
Vimpat,
Zonegran
Recently, the FDA approved the very first 3D-printed medication.
3D printing has taken the world by storm, and although it may sound like science fiction, it’s here to stay.
And the pharmaceutical industry is getting in on this innovative technology.
Posted in
Epilepsy,
Medication Issues,
News,
ResearchTags:
3D-printed medication,
Brivaracetam,
dissolves in your mouth,
improved,
Keppra,
partial-onset seizures,
Spirtam,
success,
thin layers of powdered medication
Two epilepsy drugs – Lamictal and Keppra – which are currently listed in category C may be dangerous to a fetus and should be listed in category D, according to new data. The difference between the categories is that D shows evidence of risk, but the benefits outweigh the risks…
Epilepsy Talk 